National

The U.S. secured so many COVID-19 vaccine doses through its Operation Warp Speed contracts that we may soon be sitting on a surplus, even if booster shots are needed. 

Axios Re:Cap is joined by Vanity Fair contributing editor Katherine Eban to discuss her recent reporting, which revealed how those contracts were structured and how the U.S. ended up with a stockpile it cannot distribute abroad.

Why the U.S. isn’t sharing its vaccine supply

Inside the Operation Warp Speed contracts between the U.S. government and vaccine makers.

COVID-19 vaccines

Axios Re:Cap

<p>The U.S. secured so many COVID-19 vaccine doses through its Operation Warp Speed contracts that we may soon be sitting on a surplus, even if booster shots are needed. </p><p><strong>Axios Re:Cap</strong> is joined by Vanity Fair contributing editor Katherine Eban to discuss her recent reporting, which revealed how those contracts were structured and how the U.S. ended up with a stockpile it cannot distribute abroad.</p><div><div><iframe frameborder="no" height="200" scrolling="no" src="https://playlist.megaphone.fm?e=AXIOS8085633043" width="100%"></iframe></div><div style="display:none"></div></div><span data-ad-status="NO_AD_LENGTH" data-ad-type="midStoryAd"></span>

President Biden has made the COVID-19 crisis and a post-Trump return to national unity and traditional democratic ideals his top priorities. From vaccinations to stimulus to schools, Biden is seeking bipartisan compromise while showing a willingness to use executive authority and bare Democratic majorities in the U.S. House and Senate to implement his policies. Republican leaders are navigating deep party divisions over if and how to move beyond former President Trump.

Politics & Policy

After a record economic expansion, the coronavirus pandemic sent the U.S. economy into a recession as unemployment soared to staggering heights. The country now faces urgent questions about how much stimulus is needed for reeling consumers and businesses, and what a recovery might look like.

Why the U.S. isn’t sharing its vaccine supply

Go deeper